They are not going to need money going forward with the current operation. Immediate $15M from PAR with royalties coming. Operating cash flow -7.01M (Yahoo), total cash 2.38M, debt 2.21M, they are more than ok. This is the first of 8 ANDAs filed with the FDA, that has been approved. Expecting a few more if not all, it's the drug delivery that makes their generic more attractive.